BGLC
BGLC
NASDAQ · Trading Companies & Distributors

Bionexus Gene Lab Corp

$2.19
-0.13 (-5.59%)
As of Mar 31, 5:00 PM ET ·
Financial Highlights (FY 2026)
Revenue
10.17M
Net Income
-1,708,632
Gross Margin
13.6%
Profit Margin
-16.8%
Rev Growth
-10.7%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 13.6% 13.6% 60.4% 60.4%
Operating Margin -16.5% -14.9% 8.4% 8.8%
Profit Margin -16.8% -16.0% 9.4% 7.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 10.17M 11.39M 1.58M 1.38M
Gross Profit 1.38M 1.54M 956.1K 835.6K
Operating Income -1,682,643 -1,696,022 133.2K 121.1K
Net Income -1,708,632 -1,722,218 149.1K 96.1K
Gross Margin 13.6% 13.6% 60.4% 60.4%
Operating Margin -16.5% -14.9% 8.4% 8.8%
Profit Margin -16.8% -16.0% 9.4% 7.0%
Rev Growth -10.7% -10.7% +23.5% +22.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 748.7K 864.2K
Total Equity 3.20M 3.19M
D/E Ratio 0.23 0.27
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -1,686,345 -1,794,184 198.9K 172.0K
Free Cash Flow 98.9K 88.8K